Overview
Whole body MRI uses rapid sequences and diffusion imaging to screen for metastatic disease and assess marrow pathology without ionizing radiation.
Core Components
Include coronal STIR or T2 sequences axial diffusion weighted imaging and targeted T1 sequences for focal characterization.
Acquisition Strategy
Use multistation acquisition with consistent parameters and harmonized b values for diffusion to allow whole body comparison.
Clinical Use Cases
Useful for myeloma staging metastatic survey pediatric oncology and treatment response monitoring when radiation avoidance is desired.